Demographic and clinical factors | Aboriginal | Non-Aboriginal | |
---|---|---|---|
N (%) | N (%) | p-value | |
Age in years (mean, ± SD) | 57.7 (± 15.6) | 58.5 (± 15.5) | p = 0.232 |
Sex | |||
Male | 375 (48.3) | 375 (48.3) | |
Female | 402 (51.7) | 402 (51.7) | p = 1.000 |
Decade of diagnosis | |||
1990–1999 | 284 (36.6) | 284 (36.6) | |
2000–2010 | 493 (63.5) | 493 (63.5) | p = 1.000 |
Area-level socioeconomic status | |||
Q1 (Most disadvantaged) | 431 (55.5) | 188 (24.2) | |
Q2 | 156 (20.1) | 167 (21.5) | |
Q3 | 76 (9.8) | 129 (16.6) | |
Q4 | 68 (8.8) | 146 (18.8) | |
Q5 (Least disadvantaged) | 46 (5.9) | 147 (18.9) | p < 0.001 |
Geographic remoteness | |||
Major cities | 328 (42.2) | 544 (70.0) | |
Inner regional | 58 (7.5) | 81 (10.4) | |
Outer regional | 220 (28.3) | 117 (15.1) | |
Remote | 171 (22.0) | 35 (4.5) | p < 0.001 |
Degree of spread at diagnosis | |||
Localised | 289 (37.2) | 390 (50.2) | |
Regional | 155 (20.0) | 132 (17.0) | |
Distant | 243 (31.3) | 171 (22.0) | |
Unknown/unstageable | 90 (11.6) | 84 (10.8) | p < 0.001 |
Grouped primary sites | |||
Head & neck | 110 (14.2) | 110 (14.2) | |
Gastrointestinal | 162 (20.9) | 162 (20.9) | |
Gynaecological | 54 (7.0) | 54 (7.0) | |
Genitourinary | 11 (1.4) | 11 (1.4) | |
Thoracic | 124 (16.0) | 124 (16.0) | |
Breast | 78 (10.0) | 78 (10.0) | |
Skin | 34 (4.4) | 34 (4.4) | |
Lympho haematopoietic | 39 (5.0) | 39 (5.0) | |
Prostate | 45 (5.8) | 45 (5.8) | |
Unknown primary | 46 (5.9) | 46 (5.9) | |
Other remaining sites | 74 (9.5) | 74 (9.5) | p = 1.000 |
Vital status at 31/12/2013 | |||
Alive | 220 (28.3) | 349 (44.9) | |
Non-cancer death | 96 (12.4) | 88 (11.3) | |
Cancer death | 461 (59.3) | 340 (43.8) | p < 0.001 |